Education
About Us
Working with TipRanks
Follow Us
VitaSpring Biomedical (VSBC)
OTHER OTC:VSBC
Total Valuation
VitaSpring Biomedical has a market cap or net worth of $51.78M. The enterprise value is $207.26M.
Market Cap$51.78M
Enterprise Value$207.26M
Share Statistics
VitaSpring Biomedical has 207,030,030 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding207,030,030
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
VitaSpring Biomedical’s return on equity (ROE) is 1.74 and return on invested capital (ROIC) is 195.57%.
Return on Equity (ROE)1.74
Return on Assets (ROA)-5.44
Return on Invested Capital (ROIC)195.57%
Return on Capital Employed (ROCE)1.81
Revenue Per Employee―
Profits Per Employee-10.00T>
Employee Count―
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of VitaSpring Biomedical is ―. VitaSpring Biomedical’s PEG ratio is 1.72.
PE Ratio―
PS Ratio0.00
PB Ratio-1.29K
Price to Fair Value-1.29K
Price to FCF-39.75K
Price to Operating Cash Flow-2.66K
PEG Ratio1.72
Income Statement
In the last 12 months, VitaSpring Biomedical had revenue of 0.00 and earned -4.16M in profits. Earnings per share was -0.02.
Revenue0.00
Gross Profit-219.34K
Operating Income-4.18M
Pretax Income-4.17M
Net Income-4.16M
EBITDA-3.95M
Earnings Per Share (EPS)-0.02
Cash Flow
In the last 12 months, operating cash flow was -239.51K and capital expenditures -662.00, giving a free cash flow of -240.17K billion.
Operating Cash Flow-239.51K
Free Cash Flow-240.17K
Free Cash Flow per Share>-0.01
Dividends & Yields
VitaSpring Biomedical pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-2.88
52-Week Price Change66.67%
50-Day Moving Average0.86
200-Day Moving Average0.97
Relative Strength Index (RSI)<0.01
Average Volume (3m)0.00
Important Dates
VitaSpring Biomedical upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
VitaSpring Biomedical as a current ratio of 0.14, with Debt / Equity ratio of -10.97%
Current Ratio0.14
Quick Ratio0.14
Debt to Market Cap<0.01
Net Debt to EBITDA-0.06
Interest Coverage Ratio0.00
Taxes
In the past 12 months, VitaSpring Biomedical has paid -5.38K in taxes.
Income Tax-5.38K
Effective Tax Rate<0.01
Enterprise Valuation
VitaSpring Biomedical EV to EBITDA ratio is -780.57, with an EV/FCF ratio of -39.76K.
EV to Sales0.00
EV to EBITDA-780.57
EV to Free Cash Flow-39.76K
EV to Operating Cash Flow-39.76K
Balance Sheet
VitaSpring Biomedical has $24.05K in cash and marketable securities with $329.63K in debt, giving a net cash position of -$305.58K billion.
Cash & Marketable Securities$24.05K
Total Debt$329.63K
Net Cash-$305.58K
Net Cash Per Share>-$0.01
Tangible Book Value Per Share-$0.01
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for VitaSpring Biomedical is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―